1. Arms, A. D., and Travis, C. C. (1988). Reference physiological parameters in pharmacokinetic modeling. EPA/600/6–88/004, US Environmental Protection Agency.
2. Bakke, O. M., and Scheline, R. R. (1970). Hydroxylation of aromatic hydrocarbons in the rat. Toxicol. Appl. Pharmacol.16,691–700.
3. Bitzenhofer, U. N. (1993). Entwicklung einer gasdichten Apparatur zur Untersuchung von flüchtigen Fremdstoffen mit der isoliert perfundierten Rattenleber – Kinetik von Styrol und seinem Metaboliten Styrol-7,8-oxid. GSF-Bericht 24/93, GSF–Forschungszentrum für Umwelt und Gesundheit, GmbH (Editor), Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany, ISSN 0721-1694.
4. Boogaard, P. J., de Kloe, K. P., Wong, B. A., Sumner, S. C., Watson, W. P., and van Sittert, N. J. (2000). Quantification of DNA adducts formed in liver, lungs, and isolated lung cells of rats and mice exposed to (14)C-styrene by nose-only inhalation. Toxicol. Sci.57,203–216.
5. Born, S. L., Fix, A. S., Caudill, D., and Lehman-McKeeman, L. D. (1999). Development of tolerance to Clara cell necrosis with repeat administration of coumarin. Toxicol. Sci.51,300–309.